Active	Status	Sponsor type	Region	Phase	Filter
18 Active 58 Inactive 76 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

18 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Yoon, Jung-Han
IRIS Sierra, NCT03967158: Evaluation of Effectiveness and Safety of XIENCE Sierra in Routine Clinical Practice	Active, not recruiting	N/A	2000	RoW	Xience Sierra stent	Seung-Jung Park, CardioVascular Research Foundation, Korea	Coronary Artery Disease, Coronary Disease	08/24	12/28
IRIS-Onyx, NCT02593994: Cohort in the IRIS-DES Registry	Recruiting	N/A	4500	RoW	Onyx Drug Eluting Stent group	Seung-Jung Park, CardioVascular Research Foundation, Korea, Medtronic Korea Co., Ltd.	Coronary Artery Disease, Arterial Occlusive Diseases, Cardiovascular Diseases, Percutaneous Transluminal Angioplasty	12/25	12/29
IRISFFRTandem, NCT02797561: Effect of FFR Guided Percutaneous Coronary Intervention in Coronary Tandem Lesions	Recruiting	N/A	1000	RoW	5 year Follow-up	Seung-Jung Park, CardioVascular Research Foundation, Korea	Percutaneous Transluminal Coronary Angioplasty	06/24	12/27
NCT02792075: Prognosis of Coronary Stenosis Based on Intracoronary Imaging; A Multicenter, Prospective Observational Study	Recruiting	N/A	4000	RoW	5-year Follow-up	Seung-Jung Park, CardioVascular Research Foundation, Korea	Coronary Artery Disease	01/25	06/29
IRIS FFR, NCT01366404: Study of the Natural History of FFR Guided Percutaneous Coronary Intervention	Recruiting	N/A	20000	RoW		Seung-Jung Park, CardioVascular Research Foundation, Korea, Abbott Medical Devices	Coronary Artery Disease	04/37	04/37
Kim, Sang-Wook
QWINT-2, NCT05362058: A Study of Insulin Efsitora Alfa (LY3209590) Compared to Degludec in Adults With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time	Completed	3	928	Europe, Canada, Japan, US, RoW	Insulin Efsitora Alfa, LY3209590 and Basal Insulin-FC, Insulin Degludec	Eli Lilly and Company	Diabetes, Type 2 Diabetes	04/24	04/24
NCT02792075: Prognosis of Coronary Stenosis Based on Intracoronary Imaging; A Multicenter, Prospective Observational Study	Recruiting	N/A	4000	RoW	5-year Follow-up	Seung-Jung Park, CardioVascular Research Foundation, Korea	Coronary Artery Disease	01/25	06/29
NCT04799496: A Study of Kynteles Injection (Vedolizumab) in Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease or Chronic Pouchitis	Recruiting	N/A	600	RoW		Takeda	Inflammatory Bowel Diseases, Colitis, Ulcerative, Crohn Disease	01/26	01/26
Choi, Dong-Ju
NCT05553314: Carvedilol in HF With Preserved EF	Recruiting	4	100	RoW	Carvedilol, carvedilol slow-release (SR), Placebo	Seoul National University Bundang Hospital, Samsung Medical Center, Wonju Severance Christian Hospital	Heart Failure With Preserved Ejection Fraction, Beta Blocker, Myocardial Strain	08/24	12/24
NCT05573477: Evaluation of Efficacy and Safety of ATB-1011+ATB-1012 Co-administration for Essential Hypertension and Type II Diabetes	Recruiting	3	248	RoW	ATB-1011, ATB-1012, ATB-1013, ATB-1011 placebo, ATB-1012 placebo, ATB-1013 placebo	Autotelicbio	Essential Hypertension, Diabetes Mellitus, Type 2	01/24	06/24
SMART-HF, NCT05668000: Mobile App for Heart Failure	Completed	N/A	84	RoW	Bluetooth-connected monitoring devices and a feedback system, Mobile application	Seoul National University Bundang Hospital, KT Corporation	Heart Failure	01/23	01/23
NCT05557123: Mobile App for Improving Adherence of Rivoxaban (RIVOX-AF)	Recruiting	N/A	1042	RoW	MEDI-app	Seoul National University Bundang Hospital, SAMJIN PHARM	Atrial Fibrillation	06/25	12/25
KorHF-III, NCT04329234: Korean Heart Failure Registry III	Recruiting	N/A	10000	RoW		Seoul National University Bundang Hospital, Korean Society of Heart Failure	Acute Heart Failure	12/27	12/27
Seung, Ki-Bae
IRIS FFR, NCT01366404: Study of the Natural History of FFR Guided Percutaneous Coronary Intervention	Recruiting	N/A	20000	RoW		Seung-Jung Park, CardioVascular Research Foundation, Korea, Abbott Medical Devices	Coronary Artery Disease	04/37	04/37
Rhee, Moo-Yong
HM_APOLLO, NCT05362110: A Study to Evaluate Efficacy and Safety of HCP1803 in Patients With Essential Hypertension	Completed	3	361	RoW	HCP1803-3, RLD2002, HPP2003-3, HPP2004	Hanmi Pharmaceutical Company Limited	Hypertension	06/23	06/23
HM_APOLLO, NCT06438172: A Study to Evaluate Efficacy and Safety of HCP1803 Compared to RLD2001-1 in Patients With Essential Hypertension	Recruiting	3	220	RoW	HCP1803-3, RLD2001-1, HPP2003-3, HPP2002-1	Hanmi Pharmaceutical Company Limited	Hypertension	06/25	06/25
Jeong, Myung-Ho
IRIS-MAIN, NCT01341327: Observational Study for Left Main Disease Treatment	Recruiting	N/A	10000	RoW		Seung-Jung Park, CardioVascular Research Foundation, Korea	Coronary Artery Disease	12/32	12/33
Park, Hun-sik
IRIS FFR, NCT01366404: Study of the Natural History of FFR Guided Percutaneous Coronary Intervention	Recruiting	N/A	20000	RoW		Seung-Jung Park, CardioVascular Research Foundation, Korea, Abbott Medical Devices	Coronary Artery Disease	04/37	04/37
Park, Sung-Ha
No trials found